A randomized crossover study comparing the antiplatelet effect of plavix versus generic clopidogrel

Journal of Cardiovascular Pharmacology

Volumn 60, Issue 6, 2012, Pages 495-501

  Sambu, Nalyaka ^a   Radhakrishnan, Ashwin ^b   Curzen, Nick ^b  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

antiplatelet therapy; clopidogrel; platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOPIDOGREL; GENERIC DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG WITHDRAWAL; EPISTAXIS; HUMAN; HUMAN EXPERIMENT; LOADING DRUG DOSE; MAINTENANCE DRUG DOSE; MALE; NORMAL HUMAN; OPEN STUDY; PLATELET REACTIVITY; POINT OF CARE TESTING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY;

ADENOSINE DIPHOSPHATE; ADULT; CROSS-OVER STUDIES; DRUGS, GENERIC; ENGLAND; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; THERAPEUTIC EQUIVALENCY; THROMBELASTOGRAPHY; TICLOPIDINE; TIME FACTORS;

EID: 84871560903     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31826f36bc     Document Type: Article

References (19)

1. Hobson A, Curzen N. Current status of oral antiplatelet therapies. In: Redwood S, Curzen N, Thomas M, eds. Oxford Textbook of Interventional Cardiology. New York, NY: Oxford University Press; 2010:379-394.
2. Steinhubl SR, Berger PB, Mann JT, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA. 2002;288:2411-2420.
3. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-1189.
4. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
5. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the pci-cure study. Lancet. 2001; 358:527-533.
6. Davies G. Changing the salt, changing the drug. Pharm J. 2001;266:2.
7. Jeong YH, Koh JS, Kang MK, et al. The impact of generic clopidogrel bisulfate on platelet inhibition in patients with coronary artery stents: results of the accel-generic study. Korean J Intern Med. 2010;25:154-161.
8. Neubauer H, Krüger JC, Lask S, et al. Comparing the antiplatelet effect of clopidogrel hydrogensulfate and clopidogrel besylate: a crossover study. Clin Res Cardiol. 2009;98:533-540.
9. Shim CY, Park S, Song JW, et al. Comparison of effects of two different formulations of clopidogrel bisulfate tablets on platelet aggregation and bleeding time in healthy korean volunteers: a single-dose, randomized, open-label, 1-week, two-period, phase iv crossover study. Clin Ther. 2010;32:1664-1673.
10. Kim SD, Kang W, Lee HW, et al. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, openlabel, crossover study in healthy Korean male subjects. Clin Ther. 2009; 31:793-803.
11. Di Girolamo G, Czerniuk P, Bertuola R, et al. Bioequivalence of two tablet formulations of clopidogrel in healthy argentinian volunteers: a single-dose, randomized-sequence, open-label crossover study. Clin Ther. 2010;32:161-170.
12. Sambu N, Hobson A, Curzen N. "Short" thrombelastography as a test of platelet reactivity in response to antiplatelet therapy: validation and reproducibility. Platelets. 2011;22:210-216.
13. Hobson AR, Petley GW, Dawkins KD, et al. A novel fifteen minute test for assessment of individual time-dependent clotting responses to aspirin and clopidogrel using modified thrombelastography. Platelets. 2007;18: 497-505.
14. Cotton JM, Worrall AM, Hobson AR, et al. Individualised assessment of response to clopidogrel in patients presenting with acute coronary syndromes: a role for short thrombelastography? Cardiovasc Ther. 2010;28: 139-146.
15. Hobson AR, Petley G, Morton G, et al. Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy. Thromb J. 2008;6:1.
16. Hobson AR, Qureshi Z, Banks P, et al. Gender and responses to aspirin and clopidogrel: insights using short thrombelastography. Cardiovasc Ther. 2009;27:246-252.
17. Swallow RA, Agarwala RA, Dawkins KD, et al. Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy? Platelets. 2006;17:385-392.
18. Hobson AR, Dawkins KD, Curzen NP. Antiplatelet effects of licking an aspirin tablet can be detected by thrombelastography. Acute Card Care. 2008;10:62-63.
19. Hobson AR, Qureshi Z, Banks P, et al. Effects of clopidogrel on "aspirin specific" pathways of platelet inhibition. Platelets. 2009;20: 386-390.